Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × Pharmacogenomic Variants × 90 days × Clear all

Sponsor

Conditions

Lung Neoplasms 2 Waldenstrom Macroglobulinemia 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 trametinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 dabrafenib 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 etoposide phosphate 1 Vemurafenib 1 Sirolimus 1 LY3023414 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡